The Eppendorf Group successfully ended fiscal year 2016 with Group sales of €651.5 million (prior year: €629.1 million) and revenue growth of 3.6% (4.8% when adjusted for currency effects). Income from operations (EBIT) climbed 17.1% to €139.6 million (prior year: €119.3 million), amounting ... more
Eppendorf Centrifuge 5424 R wins a ‘red dot award: product design 2011’
Eppendorf AG celebrates success in a leading global design competition which attracted 4,433 entries from 1,700 companies in over 60 nations. Centrifuge 5424 R, a 24-place microcentrifuge, has been honoured for design excellence in the life science and medicine category of ‘red dot award: product design 2011’.
The exceptionally quiet Centrifuge 5424 R is a refrigerated 24-place microcentrifuge equipped with an array of innovative usability and design features. With its very compact size, low access height and near-silent operation – even without the rotor lid – Centrifuge 5424 R fits perfectly into molecular and biological research laboratories. Four different rotors, including a Kit rotor™ to avoid tearing of spin columns with open tube lids, ensure versatility, while users can choose between rotary control knobs or a keypad. With the help of the ‘FastTemp function’ a quick pre-cooling of the centrifuge from 21 ºC to 4 ºC in only 8 minutes is possible. In addition, a temperature range of –10 ºC to +40 ºC and maximum speed of 21,130 x g (15,000 rpm) suit applications including DNA / RNA handling and pelleting of cells, membranes and particles (e.g. beads).
Rounding up the striking benefits of the Centrifuge 5424 R is the fact that it has been developed to meet latest emission and ecological requirements – thus setting new standards.
Hamburg-based Eppendorf AG acquired Calibration Technology Ltd, headquartered in the National Technology Park Limerick, Ireland, on November 1. The company will continue to be managed as a wholly owned subsidiary of Eppendorf AG by its current Managing Director, Brian Kelly. The acquisition ... more
A partial rearranging of the responsibilities in the Management Board of Eppendorf AG will be taking effect in a move designed to further drive the successful implementation of the company's strategy. This includes the creation of a new Board position which will include Sales, Marketing and ... more
Developed in line with Eppendorf’s Physio Care Concept, electric motor driven dispensing helps to minimize the strain of work in the laboratory. Eppendorf’s instinctive design minimizes the risk of RSI by lowering operation forces and positioning buttons to accommodate natural hand movements. more
Bench-scale bioprocessing for microbial and cell cultures, scale-up and scale-down, batch, fed-batch and continuous processes more
Eppendorf is introducing the new Centrifuge 5920 R, featuring extraordinary high capacity of 4 x 1000 mL or 52 x 50 mL conical tubes more
The electronic Multipette® E3 and E3x from leading life science company Eppendorf raise the bar in terms of ease of use and versatility of electronic manual dispensers. Developed in line with Eppendorf’s Physio Care Concept, electric motor driven dispensing helps to minimize the strain of w ... more
In 1950, Eppendorf introduced its first photometer to the market. From the very beginning, the focus was on obtaining maximum benefits while using the simplest handling methods. This philosophy has remained unchanged to this day. The current portfolio demonstrates Eppendorfs' expertise in p ... more
The Eppendorf line of epMotion automated liquid handling systems is designed to help you automate routine pipetting tasks to free up your time. Not only is the epMotion one of the most accurate pipetting stations on the market, by virtue of automation it helps you to eliminate manual pipett ... more
Experimentation involving human stem cells (HSCs) is one of the fastest growing fields in research and development due, in large part, to its potential for revolutionizing human disease treatment. There are multiple HSC platforms being investigated, including human mesenchymal stem cells ( ... moreWebinarOn-Demand
When was the last time you were upset about non-reproducible results of your experiment? Even though you checked all variables including the pipetting system used in your experiment, you were unable to find the cause. In many cases the assumption is made that the pipetting system, consisti ... moreWebinarOn-Demand
It has been a decade since Shinya Yamanaka and Kazutoshi Takahashi first reported the Nobel Prize winning discovery of induced pluripotent stem cells (iPSCs). Since then the technology has created new opportunities in understanding human development and has become an important tool in disea ... more
- 1Groundbreaking experimental method will speed up protein analysis substantially
- 2We are much more unique than assumed
- 3PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion
- 4Shimadzu acquires specialist for isotope labeled standards
- 5LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
- 6New three-in-one blood test opens door to precision medicine for prostate cancer
- 7State-of-the-art text mining technologies for chemistry
- 8Eurofins expands its footprint in the Balkan region
- 9New sensors could enable more affordable detection of pollution and diseases
- 10New femto-camera with quadrillion fractions of a second resolution
- MRC Technology and Biocartis initiate development of liquid biopsy test for ...
- Agilent Technologies Receives Multiple Awards at Scientific Conference in China
- Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds are investing to ...
- Carl Zeiss Meditec AG wins patent infringement action on trifocal intraocula ...
- Zika virus test receives FDA emergency use authorization
- Shimadzu acquires specialist for isotope labeled standards
- Groundbreaking experimental method will speed up protein analysis substantially
- We are much more unique than assumed
- LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
- PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion